Quorum tapped as central IRB for cancer research network
Quorum Review IRB is collaborating with a global cancer research network to help improve clinical trial start-up and patient recruitment processes.
The Academic and Community Cancer Research United (ACCRU) is a cancer research network including more than 110 academic medical centers and community oncology practices globally.
The network conducts industry-sponsored and investigator-initiated Phase II and III cancer treatment and symptom management clinical trials.
To streamline this work, ACCRU is collaborating with Quorum, which provides IRB and IBC review, API integrations, and consulting services.
As per the collaboration, Quorum will be an optional IRB for network members.
Tanios Bekaii-Saab, MD, interim chair, ACCRU said the collaboration is part of the network’s efforts “to improve clinical trial administration processes” so its members can quickly activate and enroll patients.
